Advances in cardiovascular interventional techniques have enabled percutaneous treatment for a wide spectrum of non-coronary cardiovascular diseases, also known as ‘structural heart diseases (SHD)’. As these therapies are performed without an open-heart surgery, the use of echocardiography is crucial for detailed visualisation of cardiac anatomy, and to provide guidance for optimal success of these catheter-based interventions. This review will describe the key role of the echocardiographic techniques and imaging protocols that are currently used in different catheter-based SHD interventions.
ZamoranoJLBadanoL PBruceCChanKLGoncalvesAHahnRT. EAE/ASE recommendations for the use of echocardiography in new transcatheter interventions for valvular heart disease. Eur Heart J2011;32(17):2189–214 doi: 10.1093/eurheartj/ehr259.
FaletraFFNuciforaGHoSY. Imaging the atrial septum using real-time three-dimensional transesophageal echocardiography: Technical tips, normal anatomy, and its role in transseptal puncture. J Am Soc Echocardiogr2011;24(6):593–9 doi: 10.1016/j.echo.2011.01.022.
4.
LangRMBierigMDevereuxRBFlachskampfFAFosterEPellikkaPA. Recommendations for chamber quantification: A report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr2005;18(12):1440–63 doi: 10.1016/j.echo.2005.10.005.
5.
RayS. The echocardiographic assessment of functional mitral regurgitation. Eur J Echocardiogr2010;11(10):i11–7 doi: 10.1093/ejechocard/jeq121.
6.
SchubertSKainzSPetersBBergerFEwertP. Interventional closure of atrial septal defects without fluoroscopy in adult and pediatric patients. Clin Res Cardiol2012;101(9):691–700 doi: 10.1007/s00392-012-0445-1.
SilvestryFEKadakiaMBWillhideJHerrmannHC. Initial experience with a novel real-time three-dimensional intracardiac ultrasound system to guide percutaneous cardiac structural interventions: A phase 1 feasibility study of volume intracardiac echocardiography in the assessment of patients with structural heart disease undergoing percutaneous transcatheter therapy. J Am Soc Echocardiogr2014;27(9):978–83 doi: 10.1016/j.echo.2014.04.022.
LeonMBSmithCRMackMMillerDCMosesJWSvenssonLG. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med2010;363(17):1597–607 doi: 10.1056/NEJMoa1008232.
11.
SmithCRLeonMBMackMJMillerDCMosesJWSvenssonLG. Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med2011;364(23):2187–98 doi: 10.1056/NEJMoa1103510.
12.
NishimuraRAOttoCMBonowROCarabelloBAErwinJ PGuytonRA. 2014 AHA/ACC guideline for the management of patients with valvular heart disease: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Thorac Cardiovasc Surg2014;148(1):e1–132 doi: 10.1016/j.jtcvs.2014.05.014.
13.
CribierAEltchaninoffHBashABorensteinNTronCBauerF. Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: First human case description. Circulation2002;106(24):3006–8 doi: 10.1161/01.CIR.0000047200.36165.B8.
14.
ZamoranoJLGonçalvesALangR. Imaging to select and guide transcatheter aortic valve implantation. Eur Heart J2014;35(24):1578–87 doi: 10.1093/eurheartj/eht569.
15.
PiazzaNde JaegerePSchultzCBeckerAESerruysPWAndersonRH. Anatomy of the aortic valvar complex and its implications for transcatheter implantation of the aortic valve. Circ Cardiovasc Interv2008;1(1):74–81 doi: 10.1161/CIRCINTERVENTIONS.108.780858.
16.
NgACDelgadoVvan der KleyFShanksMvan de VeireNRBertiniM. Comparison of aortic root dimensions and geometries before and after transcatheter aortic valve implantation by 2- and 3-dimensional transesophageal echocardiography and multislice computed tomography. Circ Cardiovasc Imaging2010;3(1):94–102 doi: 10.1161/CIRCIMAGING.109.885152.
17.
TamboriniGFusiniLGripariPMuratoriMCefalùCMaffessantiF. Feasibility and accuracy of 3DTEE versus CT for the evaluation of aortic valve annulus to left main ostium distance before transcatheter aortic valve implantation. JACC Cardiovasc Imaging2012;5(6):579–88 doi: 10.1016/j.jcmg.2012.02.012.
18.
FosterE. Clinical practice. Mitral regurgitation due to degenerative mitral-valve disease. N Engl J Med2010;363(2):156–65 doi: 10.1056/NEJMcP0906782.
19.
FeldmanTWassermanHSHerrmannHCGrayWBlockPCWhitlowP. Percutaneous mitral valve repair using the edge-to-edge technique: Six-month results of the EVEREST Phase I Clinical Trial. J Am Coll Cardiol2005;46(11):2134–40 doi: 10.1016/j.jacc.2005.07.065.
20.
FeldmanTKarSRinaldiMFailPHermillerJSmallingR. Percutaneous mitral repair with the MitraClip system: Safety and midterm durability in the initial EVEREST (Endovascular Valve Edge-to-Edge REpair Study) cohort. J Am Coll Cardiol2009;54(8):686–94 doi: 10.1016/j.jacc.2009.03.077.
21.
FeldmanTFosterEGlowerDGKarSRinaldiMJFailPS. Percutaneous repair or surgery for mitral regurgitation. N Eng J Med2011;364(15):1395–406 doi: 10.1056/NEJMoa1009355.
22.
WhitlowPLFeldmanTPedersenWRLimDSKippermanRSmallingR. Acute and 12-month results with catheter-based mitral valve leaflet repair: The EVEREST II (Endovascular Valve Edge-to-Edge Repair) High Risk Study. J Am Coll Cardiol2012;59(2):130–9 doi: 10.1016/j.jacc.2011.08.067.
23.
LancellottiPMouraLPierardLAAgricolaEPopescuBATribouilloyC. European Association of Echocardiography recommendations for the assessment of valvular regurgitation. Part 2: Mitral and tricuspid regurgitation (native valve disease). Eur J Echocardiogr2010;11(4):307–32 doi: 10.1093/ejechocard/jeq031.
24.
GoASHylekEMPhillipsKAChangYHenaultLESelbyJV. Prevalence of diagnosed atrial fibrillation in adults: National implications for rhythm management and stroke prevention: The AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA2001;285(18):2370–5 doi: 10.1001/jama.285.18.2370.
25.
MiyasakaYBarnesMEGershBJChaSSBaileyKRAbhayaratnaW P. Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projections for future prevalence. Circulation2006;114(2):119–25 doi: 10.1161/CIRCULATIONAHA.105.595140.
26.
ReddyVYDoshiSKSievertHBuchbinderMNeuzilPHuberK. Percutaneous left atrial appendage closure for stroke prophylaxis in patients with atrial fibrillation: 2.3-Year Follow-up of the PROTECT AF (Watchman Left Atrial Appendage System for Embolic Protection in Patients with Atrial Fibrillation) Trial. Circulation2013;127(6):720–9 doi: 10.1161/CIRCULATIONAHA.112.114389.
27.
HolmesDRKarSPriceMJWhisenantBSievertHDoshiSK. Prospective randomized evaluation of the Watchman Left Atrial Appendage Closure Device in patients with atrial fibrillation versus long-term warfarin therapy: The PREVAIL trial. J Am Coll Cardiol2014;64(1):1–12 doi: 10.1016/j.jacc.2014.04.029.
28.
CammAJLipGYDe CaterinaRSavelievaIAtarDHohnloserSH. 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: An update of the 2010 ESC Guidelines for the management of atrial fibrillation: Developed with the special contribution of the European Heart Rhythm Association. Europace. 2012;14(10):1385–413 doi: 10.1093/europace/eus305.
29.
NuciforaGFaletraFFRegoliFPasottiEPedrazziniGMoccettiT. Evaluation of the left atrial appendage with real-time 3-dimensional transesophageal echocardiography: Implications for catheter-based left atrial appendage closure. Circ Cardiovasc Imaging2011;4(5):514–23 doi: 10.1161/CIRCIMAGING.111.963892.
30.
ChueCDde GiovanniJSteedsRP. The role of echocardiography in percutaneous left atrial appendage occlusion. Eur J Echocardiogr2011;12(10):i3–10 doi: 10.1093/ejechocard/jer090.
